Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase NA 1Phase 2 1

Status

Unknown 3

Sponsor Class

OTHER_GOV 3INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Carcinoma, Hepatocellular 9Papillomavirus Infections 4Lymphoma, Non-Hodgkin 4Hypertension, Portal 4Febrile Neutropenia 4Carcinoma, Non-Small-Cell Lung 4Polycystic Ovary Syndrome 3Ovarian Cysts 3Multiple Myeloma 3Lung Neoplasms 3Cancer Pain 3Adenomatous Polyposis Coli 3Recurrence 2Rectal Neoplasms 2Prostatic Hyperplasia 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pain 2Neoplasms 2Lymphoma, B-Cell 2Lymphoma 2Liver Cirrhosis 2Leiomyoma 2Infertility 2Hyperthermia 2Hematologic Neoplasms 2Esophageal Neoplasms 2Vomiting 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Surgical Wound Infection 1

Interventions

Erythromycin 2Azithromycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × OTHER_GOV × Adenomatous Polyposis Coli × Clear all
NCT04454151 2020-07-01

FAP

Tel-Aviv Sourasky Medical Center

Phase 4 Unknown
10 enrolled
Gastrointestinal

Adenomatous Polyposis Coli

NCT02354560 2015-02-03

Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutation in Familial Adenomatous Polyposis-minors' Adjusted Version

Tel-Aviv Sourasky Medical Center

Phase 4 Unknown
15 enrolled
Gastrointestinal

Adenomatous Polyposis Coli

NCT02175914 2014-06-26

Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutations in Familial Adenomatous Polyposis

Tel-Aviv Sourasky Medical Center

Phase 4 Unknown
20 enrolled
Gastrointestinal

Adenomatous Polyposis Coli

Data powered by HemOnc (CC BY 4.0) Colophon âš¡